Latest Revenue Growth News

Jatcorp Limited's FY26 results show a 23% revenue increase to $38.9 million but a 41% larger loss attributable to owners. The company faces a material uncertainty over going concern despite improved statutory NPAT.

OncoSil Medical lifted revenues 44% in FY26 to $1.68 million and trimmed losses by 28% to $10.86 million, buoyed by key regulatory approvals including FDA HDE and Australian TGA listings. The company is poised for commercial launches in the US and Australia, with strong clinical data underpinning its growth.

Steamships Trading Company Limited saw a 14.3% revenue increase to K413.4 million in H1 2026, while net profit attributable to shareholders fell 12.2% to K21.8 million. Underlying profit rose 27.2% after adjusting for ERP expenses and insurance proceeds, with capital investment and cash flow both strengthening.

RooLife Group (ASX: RLG) reported a 268% jump in FY2026 revenue to nearly $10 million, driven by rapid growth in its own food and beverage products, including RLG Coffee in China. Despite this, the company recorded a $3.58 million net loss, weighed down by impairment charges and R&D investments in renewable energy.

Boresight Ltd (ASX: BST) recorded a 46% increase in revenue to $6.38 million for FY26, driven by global sales expansion and strategic investments including an $8 million IPO. Despite this growth, the company posted a $6.66 million net loss, largely due to increased operational expenses and significant share-based payments.

Nuchev has inked a consignment-based distribution deal to launch the Kuci women’s health probiotic range nationally through Chemist Warehouse, marking a strategic expansion into women’s health.

Teaminvest Private Group (ASX: TIP) posted a 19% increase in statutory profit for FY26, driven by strong active portfolio growth and disciplined capital allocation, while preparing to acquire Intelligent Investor in an earnings accretive deal.

Senetas Corporation reported a 4.7% rise in revenue to $20.2 million for FY2026, achieving a strong $4.4 million operating cash flow turnaround. The company advanced its AI governance platform while maintaining a robust sales pipeline and capital management strategy.

4DMedical’s CT:VQ™ lung imaging technology secured FDA clearance and CMS reimbursement, driving rapid adoption in top US medical centres and expanding its addressable market to $3 billion with new clinical programs and European contracts.

SPC Global reported a 27% rise in normalised EBITDA for FY26 to $38.5 million, supported by a $100 million equity raise that halved net leverage. The company’s strategic pivot to higher-margin branded products and operational efficiencies set the stage for targeted double-digit revenue and EBITDA growth in FY27.

OpenLearning Limited accelerated its SaaS revenue growth to a record $3.27 million in HY2026, boosting gross margin to 63% and cutting its EBITDA loss by over a quarter amid expanding multi-year institutional contracts.

Micro-X Limited lifted revenues by 16% to $15.1 million for FY26 but posted a $9.9 million net loss, narrowing from the prior year. The company advanced key medical imaging milestones and initiated a strategic reset to sharpen commercial focus and reduce costs.